英语语法分析

Safety and tolerability profiles of the combination regimen were as expected, with no new or unexpected toxicities observed.

联合治疗的安全性和耐受性数据也如预期相同，在实验中没有观察到新的或者意外的毒性现象。

Main Outcome Measure: to evaluate the efficacy, safety, and tolerability of the octreotide implant during 24 weeks of treatment.

主要评价指标：在24周的治疗期间评估评估奥曲肽植入物的有效性、安全性和耐受性。

The investigating physicians assessed the skin tolerability of Hirudoid and Hirudoid forte as good or very good in 97,3 % of all cases.

调查医师对喜疗妥或特强喜疗妥的皮肤耐受性评价为好或非常好的病例百分比为97.3％。